The expression of the four diagnostic biomarkers demonstrated that RA patients in Cluster A exhibited lower expression of AKR1C3, POLE4, and MCEE than those in Cluster B (Figure 11D). This evidence concerns the gene AKR1C3 and rheumatoid arthritis.